Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
about
Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome.Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome.Ovarian hypertension: polycystic ovary syndrome.Insulin sensitivity and secretory status of a healthy malay population.Adiponectin in women with polycystic ovary syndromeBiomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study.Downregulation of adiponectin system in granulosa cells and low levels of HMW adiponectin in PCOS.Obesity and the role of gut and adipose hormones in female reproduction.Adiponectin and polycystic ovary syndrome.Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistanceThe effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome.Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis.The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis.Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.Walnuts (Juglans regia) Chemical Composition and Research in Human Health.Polycystic ovary syndrome, adipose tissue and metabolic syndrome.The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome.Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.Adiponectin and resistin concentrations after glucose load in adolescents with polycystic ovary syndrome.Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS.Serum resistin and adiponectin levels in women with polycystic ovary syndrome.Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones.Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients.Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study.Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis.Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome.Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program.Obesity and insulin resistance in women with polycystic ovary syndrome.Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
P2860
Q33589232-3F65A10E-DA61-4BEF-92D8-46EEDA82D7DDQ34161009-E026E4FD-F24F-4AA5-88BA-6BA0AED8F473Q35660296-15B5904A-4E59-4431-B92E-D072733BAB6FQ35950688-EAD156C5-92CE-4151-B70D-C5B075B26557Q36058331-D6EBF78A-E9A5-4A4B-BDDD-10F369A9A069Q36180254-D901D13E-BBBA-4B9C-B6CE-C2E14E716DBFQ36474828-AD39F6C4-0A0A-42A8-ABBF-2A60FE0B6F11Q36507088-E04426B6-1BA1-41B5-B1F0-EF1457FAE11EQ36822774-5F4B1E72-A62C-4396-AAB9-A31A4F978C5AQ36931223-A14DE84D-663B-45BB-9462-7593C0A9A23AQ37402281-B1A5753F-396F-4E07-91C2-3FC8FED35C98Q37406532-D2986B9A-E889-4554-9F57-670F0E3A9407Q37990356-159622EF-5181-4FE3-84B0-49E126F905DDQ38024326-CEC600E5-8DFD-4180-87CB-6E99C75CD180Q38056783-449BE8DC-BBCD-490C-A357-3DEDB2D0CCF5Q38302430-C2A10338-1DA9-4873-BE16-7CA9E36864ECQ38369343-BEA513C6-C6F4-4AD2-A5A3-B2BCB31B3774Q39393050-225D8454-8A13-4B53-9B14-2A80074F36FEQ40196769-5227541C-99B3-4CC8-BC5E-4CC8506C8803Q41056671-94114D18-380A-477F-990A-890BEE2931DFQ42518375-E0DE86F9-5796-4014-B5B6-4D03D67FBA69Q43101349-CC9D8CF1-4157-40C7-8898-33A2224CCBBCQ43260422-60BECD11-B692-4578-B6D2-CDFF78348460Q45917078-71F8C7BC-9CFE-4277-AB1F-B14968FDB38CQ45958344-E8212EF4-4C0B-480C-ACED-9CF70F73EB93Q46029238-3EE1BC2F-B1A2-4340-964E-5114B54E55D1Q46121424-6CACBDF3-15C8-4D8E-B406-0637824E58F9Q46255380-2F7BDB0D-4549-44E2-8D44-B1EA41F85041Q46464037-40FA475E-5F0D-4E97-9074-BB5F20893345Q47936941-9252ED25-C7DF-48BD-B766-663B2F0E4F02Q47960274-24FD2E2C-0363-4831-83B7-64D74A4B6280Q50002422-D91597F7-2B1B-4677-9023-E700FE12450EQ51399542-0D5E8A2D-E5B2-48F2-8ACD-17B51F13DC97Q51450568-92E8773A-37B8-4870-A5B5-AB68635746F4
P2860
Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Adiponectin is independently a ...... ith polycystic ovary syndrome.
@en
Adiponectin is independently a ...... ith polycystic ovary syndrome.
@nl
type
label
Adiponectin is independently a ...... ith polycystic ovary syndrome.
@en
Adiponectin is independently a ...... ith polycystic ovary syndrome.
@nl
prefLabel
Adiponectin is independently a ...... ith polycystic ovary syndrome.
@en
Adiponectin is independently a ...... ith polycystic ovary syndrome.
@nl
P2093
P2860
P50
P1476
Adiponectin is independently a ...... with polycystic ovary syndrome
@en
P2093
Christof Schöfl
Georg Brabant
Hans W Schlösser
Thilo Schill
Uta Wegewitz
P2860
P304
P356
10.1111/J.1365-2265.2004.02159.X
P577
2004-12-01T00:00:00Z